Company: ABUS
Filing Date: 2025-01-13
Form Type: 8-K
Source: 0001171843-25-000193
Chunk: 0

Company: Arbutus Biopharma Corp
Filing Date: 2025-01-13
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On January 13, 2025, Arbutus Biopharma Corporation (the "Company") issued a press release (the "Press Release") announcing its 2025 corporate update and providing certain estimated financial information, including its estimated cash, cash equivalents and investments as of December 31, 2024 and its estimated 2024 cash burn. The amounts included in the Press Release are preliminary, have not been audited and are subject to change upon completion of the Company's audited financial statements for the year ended December 31, 2024. Additional information and disclosures would be required for a more complete understanding of the Company's financial position and results of operations as of December 31, 2024. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference herein.

On January 13, 2025, the Company posted an updated corporate presentation on its website at www. arbutusbio. com (the "Corporate Presentation"), which included the Company's estimated cash, cash equivalents and investments as of December 31, 2024. A copy of the Corporate Presentation is filed herewith as Exhibit 99.2 and is incorporated by reference herein.

Item 8.01. Other Events.

On January 13, 2025, the Company issued the Press Release, a copy of which is filed herewith as Exhibit 99.1 hereto and is incorporated by reference herein.

A copy of the Corporate Presentation is filed herewith as Exhibit 99.2 hereto and is incorporated by reference herein.